COMMUNIQUÉS West-GlobeNewswire

Gartner Names ABBYY a Leader in its 2026 Magic Quadrant for Intelligent Document Processing
11/09/2026
AUSTIN, Texas, Sept. 11, 2026 (GLOBE NEWSWIRE) -- ABBYY has been named a Leader in the 2026 Gartner Magic Quadrant for Intelligent Document Processing (IDP). It is ABBYY's second recognition in the Gartner second [...]
FDA approves Pharming’s Joenja® as first treatment for children with APDS in the U.S.
11/09/2026
FDA approval expands Joenja indication to include children with activated phosphoinositide 3-kinase delta (PI3Kδ) syndrome (APDS) ages 4 to 11 who weigh at least 27kg Newly approved Joenja doses are expected to be [...]
Omniscient Secures Third FDA Clearance, Extending Its Connectomic Platform into the Fast-Growing Deep Brain Stimulation Market
11/09/2026
The clearance of Quicktome’s Deep Brain (DB) workflow marks Omniscient's third FDA milestone and its entry into DBS, advancing the company's strategy to provide actionable brain insights across neurosurgery and [...]
MEDIA ADVISORY: New Report Tracking Under-Used Hospitals, Deficits, Cuts & Inequities in Health Care Across Ontario
11/09/2026
Attn: Assignment Editor/News Desk TORONTO, Sept. 11, 2026 (GLOBE NEWSWIRE) -- The Ford government has continued to expand its privatization of local public hospitals' services. A raft of new private clinics is planned [...]
Vystar Enters the Digital Economy Through R3alm Ownership
11/09/2026
Vystar’s 50 percent interest places the public company inside r3alm’s developing 22-module AI, digital-finance and tokenized-asset ecosystem BOSTON, MA, Sept. 11, 2026 (GLOBE NEWSWIRE) -- R3alm and Vystar Corporation ( [...]
Orion Corporation: Acquisition of own shares during week 37, 2026
11/09/2026
Orion Corporation: Acquisition of own shares during week 37, 2026 The share buybacks form part of the share buyback programme that Orion Corporation announced on 27 August 2026. The buyback programme runs from 1 [...]
Sanofi: Informations relatives au nombre de droits de vote et d'actions - AOUT 2026
11/09/2026
Informations relatives au nombre total de droits de vote et d’actions prévues par l’article L. 233-8 II du Code de commerce et l’article 223-16 du Règlement général de l’Autorité des Marchés Financiers Sanofi Société [...]
Sanofi: Information concerning the total number of voting rights and shares - August 2026
11/09/2026
Information concerning the total number of voting rights and shares, provided pursuant to article L. 233-8 II of the Code de commerce (the French Commercial Code) and article 223-16 of the Règlement général de l’ [...]
Daré Bioscience Presentation for H.C. Wainwright 28th Annual Global Investment Conference Now Available On-Demand
11/09/2026
View the video webcast here SAN DIEGO, Sept. 11, 2026 (GLOBE NEWSWIRE) -- Daré Bioscience, Inc. (NASDAQ: DARE), a purpose-driven health biotech company solely focused on closing the gap in women's health between [...]
Outlook Therapeutics Fireside Chat from H.C. Wainwright Conference Now Available On-Demand
11/09/2026
Fireside chat featuring Bob Jahr, Chief Executive Officer, and H.C. Wainwright Managing Director & Senior Biotechnology Equity Research Analyst Access the video webcast here ISELIN, N.J., Sept. 11, 2026 (GLOBE [...]
Spectral Medical Provides Update Following In-Person FDA 100-Day Meeting for PMX PMA
11/09/2026
• Company gains further clarity on the additional information required to advance its PMA review • FDA did not request an additional clinical trial following its 100-day review of the PMA application • Company does not [...]
NRx Pharmaceuticals (Nasdaq: NRXP) Subsidiary HOPE Therapeutics Begins Training and Deployment of Zeta Surgical's FDA-Cleared Robotic TMS System
11/09/2026
HOPE is the first Interventional Psychiatry network to deploy Zeta Surgical's newly FDA-cleared TMS Robotic System; the HOPE clinical team is completing orientation and training at Zeta Surgical's headquarters in Boston [...]
Prelude Therapeutics to Participate in the H.C. Wainwright 28th Annual Global Investment Conference
11/09/2026
WILMINGTON, Del., Sept. 11, 2026 (GLOBE NEWSWIRE) -- Prelude Therapeutics Incorporated (Prelude) (Nasdaq: PRLD), a clinical-stage precision oncology company, announced today that the Company will participate in the H.C [...]
ALK to present at the Morgan Stanley Global Healthcare Conference in New York
11/09/2026
ALK (ALKB:DC / Nasdaq Copenhagen: ALK B) today announced that the company’s Executive Vice President and CFO, Claus Steensen Sølje, is scheduled to participate in a fireside chat at the Morgan Stanley 24th Annual Global [...]
Immutep Outlines Focused Development Strategy for Eftilagimod Alfa (“efti”)
11/09/2026
Future registration-directed clinical development of efti is intended to focus on head and neck squamous cell carcinoma (HNSCC) in patients with negative PD-L1 expression (Combined Positive Score (CPS) < 1) and the [...]
Clearmind Enrolls First Patients with Alcohol Use Disorder in CMND-100 Clinical Trial
11/09/2026
Vancouver, Canada, Sept. 11, 2026 (GLOBE NEWSWIRE) -- Clearmind Medicine Inc. (Nasdaq: CMND) (the “Company”), a clinical-stage biopharmaceutical company advancing non-hallucinogenic psychedelic-derived neuroplastogen [...]
Tempest Therapeutics Announces Up to $7.5 Million Private Placement
11/09/2026
$2.5 million upfront with up to approximately $5 million of potential aggregate gross proceeds upon the exercise in full of warrants BRISBANE, Calif. , Sept. 11, 2026 (GLOBE NEWSWIRE) -- Tempest Therapeutics, Inc. ( [...]
GT Biopharma to Host Live Company Presentation on the Development of TriKE® Platform for Cancer Treatment, September 11, 2026
11/09/2026
SAN FRANCISCO, CALIFORNIA, Sept. 11, 2026 (GLOBE NEWSWIRE) -- GT Biopharma, Inc. (the “Company”) (NASDAQ: GTBP), a clinical stage immuno-oncology company focused on developing innovative therapeutics based on the [...]
Allarity Therapeutics Announces Strategic Capital Allocation for Filing of SPAC Registration Statement
11/09/2026
TARPON SPRINGS, Fla., September 11, 2026 – Allarity Therapeutics, Inc. (“Allarity” or the “Company”) (NASDAQ: ALLR), a Phase 2 clinical-stage pharmaceutical company dedicated to developing stenoparib—a differentiated [...]

Pages